Global EditionASIA 中文双语Français
Business
Home / Business / Policies

Houses keen on A shares, innovation

StanChart remains overweight on China equities within Asia ex-Japan

By JIANG XUEQING | CHINA DAILY | Updated: 2026-05-20 07:14
Share
Share - WeChat
A bronze bull stands outside the Shanghai Stock Exchange building in Shanghai. [Photo/VCG]

Global financial institutions are turning increasingly bullish on Chinese equities, betting that resilient economic growth, policy support, rapid technological innovation and a recovery in corporate earnings will drive a fresh valuation re-rating of China's stock market.

UBS Global Wealth Management's chief investment office recently said it continues to view Chinese equities as attractive overall, with a particular preference for the technology sector, while also being upbeat on power and equipment, healthcare and selected income-oriented sectors.

For long-term investors, UBS believes Chinese companies that successfully expand overseas, strengthen execution capabilities and globalize their operations present especially compelling structural opportunities.

Standard Chartered said in its May 2026 global market outlook report that the bank remains overweight on Chinese equities within Asia ex-Japan, and that its pro-risk positioning favors a rotation toward more growth-oriented sectors.

"Our overweight on China reflects an attractive valuation re-rating potential amid resilient growth and policy support," Standard Chartered said, adding that its overweight position in Chinese equities should benefit from strong earnings in the tech sector and renewed focus on the artificial intelligence theme.

"Tech innovation remains a priority under China's 15th Five-Year Plan (2026-30). The strong AI-related IPO pipeline supports investor sentiment, while valuations are reasonable," the report said.

Standard Chartered expects China's tech and communication services sectors to continue benefiting from technological innovation and supportive government policies. Meanwhile, the banking group said it sees strengthening momentum in the healthcare sector, reflected in the improving quality and long-term potential of Chinese drug discovery and innovation.

According to market tracker Wind Info, as of May 13, foreign institutions had surveyed nearly 440 A-share listed companies since the beginning of the second quarter, with electronics, pharmaceuticals, machinery equipment and power equipment emerging as key areas of focus.

The three sectors attracting the greatest attention from foreign institutional investors in this round of research were the AI industrial chain, robotics and industrial automation, and medical devices and innovative drugs.

As of April 30, 5,507 A-share listed companies had released their first-quarter earnings. Among them, 4,042 companies reported profits, while 2,846 companies posted year-on-year net profit growth. The 5,507 listed companies reported combined net profit of 1.6 trillion yuan ($235.31 billion) in the first quarter, a year-over-year increase of 6.76 percent.

Meng Lei, China equity strategist at UBS Securities, said this year's earnings recovery has been primarily driven by the nonfinancial sector.

First-quarter earnings in the sector rose 11.8 percent year-on-year, significantly higher than the 0.8 percent growth recorded for full year 2025. This reflects a recovery in aggregate economic demand and corporate profitability. In particular, demand expansion driven by AI and technological self-reliance themes has fueled continued rapid earnings growth in the broader technology sector, Meng said.

Analysts at UBS Securities believe that amid rising global uncertainty and heightened geopolitical volatility, the risk resilience and low-correlation characteristics of Chinese assets are becoming increasingly attractive.

Meng added that the upward momentum of the A-share market mainly stems from two sources: the recovery in corporate earnings, which is expected to deliver double-digit growth and become the key driver of market gains this year; and the continued inflow of incremental capital from various channels, which, amid ample liquidity and the steadily rising strategic importance of the A-share market, will provide strong support for higher stock valuations.

"We have revised up our forecast for full-year 2026 A-share earnings growth to 11 percent from the previous estimate of 8 percent," Meng said.

He added that in an environment where high-yield investment options remain scarce and the principle that "housing is for living in, not for speculation" has become firmly entrenched, household savings are continuing to shift gradually into financial assets. The steady inflow of medium and long-term capital is expected to provide ongoing support for further gains in market valuations.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE